TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ABOS

Acumen Pharmaceuticals Inc

Healthcare · Biotechnology

2.70$ +2.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Acumen Pharmaceuticals Inc (ABOS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 116 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABOS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
286 310 301 289 267 239 204 172 142 123 134 116
219 247 256 267 208 178 155 148 132 122 133 116
95 67 47 68 33 36 30 37 47 54 52 59
215 244 253 260 200 172 149 143 127 117 128 110
0.0 0.2 0.2 0.1 0.3 0.4 0.4 0.3 0.4 0.6 0.8 1.0
0.1 0.0 0.1 0.1 0.2
0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0
6.1 43 39 45 50 57 49 55 49 52 46 59
6.1 13 8.5 15 20 28 19 25 22 30 29 47
0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 3.7 8.9 14 20
1.4 1.4 3.1 4.2 2.3 5.6 1.1 2.1 0.7 0.6 1.7 13
27 28 28 28 28 29 30 27 22 17 12
280 267 262 244 217 182 156 117 93 70 87 57
-206 -223 -238 -258 -288 -325 -354 -395 -421 -446 -467 -500
54 58 60 60 60 60 61 61 61 61 63 72

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?